GenVec, Inc. (GNVC) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 41

GenVec, Inc. (GNVC) - Financial and Strategic SWOT Analysis Review

Summary

GenVec, Inc. (GenVec) is a clinical stage bio-pharmaceutical company engaged in the development of novel gene-based therapeutic drugs and vaccines. The company’s product candidates include, TNFerade, its lead therapeutic product candidate which is being developed in the clinical trials for the treatment cancers. It is also focuses on the development of novel treatments for hearing loss and balance disorders through a worldwide collaboration with Novartis. Additionally, the company develops vaccines for infectious diseases such as HIV, seasonal and pandemic flu, malaria, herpes simplex virus type 2 (HSV-2) and foot and mouth disease using its proprietary adenovector technology. GenVec is headquartered in Gaithersburg, Maryland, the US.

GenVec, Inc. Key Recent Developments

Aug 09, 2011 GenVec Reports Total Revenue Of $4.7m For Q2 2011
Jun 22, 2011 GenVec Announces Board Appointments
May 09, 2011 GenVec Reports Net Loss Of $2.2m For Q1 2011
May 05, 2011 Genvec Regains Compliance With Nasdaq Listing Requirements
Mar 10, 2011 GenVec Reports Net Loss Of $1m For Q4 2010

This comprehensive SWOT profile of GenVec, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
GenVec, Inc. - Key Facts
GenVec, Inc. - Key Employees
GenVec, Inc. - Key Employee Biographies
GenVec, Inc. - Major Products and Services
GenVec, Inc. - Pharmaceutical Pipeline Products Data
GenVec, Inc., Pipeline Products by Therapy Area
GenVec, Inc., Pipeline Products by Development Phase
GenVec, Inc. - History
GenVec, Inc. - Company Statement
GenVec, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
GenVec, Inc. - Business Description
GenVec, Inc. - SWOT Analysis
SWOT Analysis - Overview
GenVec, Inc. - Strengths
Strength - Strong Liquidity
Strength - Adenovirus Vector Technology
Strength - Patent Protected Portfolio
Strength - Strong Research and Development Activities
Weakness - Continued Losses
Opportunity - Orphan Drug Designation
Opportunity - Strategic Agreements and Collaborations
Opportunity - Large Cancer Treatment Market
Opportunity - Rising Healthcare Expenditure in the US
Threat - Risk of Delay in Manufacturing Operations
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Intense Market Competition
GenVec, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GenVec, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
GenVec, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
GenVec, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 09, 2011: GenVec Reports Total Revenue Of $4.7m For Q2 2011
Jun 22, 2011: GenVec Announces Board Appointments
May 09, 2011: GenVec Reports Net Loss Of $2.2m For Q1 2011
May 05, 2011: Genvec Regains Compliance With Nasdaq Listing Requirements
Mar 10, 2011: GenVec Reports Net Loss Of $1m For Q4 2010
Jan 25, 2011: GenVec And US Naval Medical Research Center Collaborate On Vaccine For Dengue Fever
Nov 09, 2010: GenVec Announces Extension To Regain Compliance With NASDAQ's Minimum Bid Price Rule
Nov 08, 2010: GenVec Reports Net Loss Of $2.4 Million For Q3 2010
Nov 05, 2010: GenVec Reports Listing Transfer To Nasdaq Capital Market
Nov 02, 2010: GenVec Receives Grant For Qualifying Therapeutic Development Project
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
GenVec, Inc., Key Facts
GenVec, Inc., Key Employees
GenVec, Inc., Key Employee Biographies
GenVec, Inc., Major Products and Services
GenVec, Inc., Number of Pipeline Products by Therapy Area
GenVec, Inc., Number of Pipeline Products by Development Stage
GenVec, Inc., Pipeline Products By Therapy Area and Development Phase
GenVec, Inc., History
GenVec, Inc., Key Competitors
GenVec, Inc., Ratios based on current share price
GenVec, Inc., Annual Ratios
GenVec, Inc., Interim Ratios
GenVec, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
GenVec, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
GenVec, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
GenVec, Inc., Pipeline Products by Therapy Area
GenVec, Inc., Pipeline Products by Development Phase
GenVec, Inc., Performance Chart (2006 - 2010)
GenVec, Inc., Ratio Charts
GenVec, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
GenVec, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011

MedImmune, LLC
Vical Incorporated
Sanofi
Lorus Therapeutics Inc
MediGene, Inc
Celgene Corporation
Amgen Inc.
AB Science
Abraxis BioScience, Inc.
MediGene AG

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• eBay - Strong Execution
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile